| 期 |
栏目 |
标题 |
文件 |
| 卷 92, 编号 6 (2020) |
Original articles |
The balance of proinflammatory cytokines and Treg cells in chronic glomerulonephritis |
(Rus)
|
| 卷 92, 编号 6 (2020) |
Original articles |
Changes in metabolic parameters and glomerular filtration rate in patients with morbid obesity after bariatric surgery |
(Rus)
|
| 卷 92, 编号 6 (2020) |
Original articles |
Modern view on treatment of membranous nephropathy |
(Rus)
|
| 卷 95, 编号 9 (2023) |
Reviews |
The role of mineralocorticoid receptors hyperactivation in the development of cardiorenal complications in patients with diabetes mellitus, perspective of the selective nonsteroidal mineralocorticoid receptors antagonist’s treatment: A review |
(Rus)
|
| 卷 93, 编号 6 (2021) |
Editorial |
Kidney injury associated with antitumor therapy: focus on the adverse events of modern immuno-oncological drugs |
(Rus)
|
| 卷 93, 编号 10 (2021) |
History of medicine |
The Rehberg–Tareev test in assessing the glomerular filtration rate |
(Rus)
|
| 卷 94, 编号 6 (2022) |
Editorial |
Lupus nephritis in the XXI century |
(Rus)
|
| 卷 94, 编号 6 (2022) |
Reviews |
Modern view on the complement system role in membranous nephropathy |
(Rus)
|
| 卷 94, 编号 6 (2022) |
History of medicine |
Kidney damage caused by lead exposure: historical aspects |
(Rus)
|
| 卷 95, 编号 6 (2023) |
Editorial |
State-of-the-art paradigm of corticosteroid therapy for immune-mediated inflammatory kidney diseases |
(Rus)
|
| 卷 95, 编号 6 (2023) |
Original articles |
Clinical significance of the determination of antibodies to thrombospondin type 1 containing domain 7A (THSD7A) in membranous nephropathy |
(Rus)
|
| 卷 95, 编号 6 (2023) |
Reviews |
Frailty and chronic kidney disease – the real problem of modern nephrology: A review |
(Rus)
|
| 卷 96, 编号 6 (2024): Нефрология |
Original articles |
Idiopathic membranous nephropathy with focal segmental sclerosis |
(Rus)
|
